Results 161 to 170 of about 21,706 (181)

Clinical Pharmacokinetics of Allopurinol

Clinical Pharmacokinetics, 2012
George Murrell, G A C Murrell
exaly  

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response

Clinical and Experimental Allergy, 2013
Carlo Rodolfo Largiadèr, Werner J. Pichler, D Yerly   +2 more
exaly  

Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study

American Journal of Medicine, 2016
Anton Pottegård, Hanne Lindegaard, Jesper Hallas   +2 more
exaly  

High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease.

Journal of the American College of Cardiology, 2013
Jacob George, Allan D. Struthers, Chim C. Lang   +2 more
exaly  

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout

Current Rheumatology Reports, 2009
Robert Terkeltaub
exaly  

An open-label, 6-month study of allopurinol safety in gout: The LASSO study

Seminars in Arthritis and Rheumatism, 2015
Nicola Dalbeth, Scott Baumgartner
exaly  

HLA-B*58:01 Allele is Associated with Augmented Risk for Both Mild and Severe Cutaneous Adverse Reactions Induced by Allopurinol in Han Chinese

Pharmacogenomics, 2012
Zhiyun Wei, Jun-Yu Zhang, Sheng-Ying Qin
exaly  

Allopurinol

Reactions Weekly, 2014
openaire   +1 more source

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis

Rheumatology, 2018
Jeffrey Miner, Ruth Topless, Lisa Stamp
exaly  

Highly Acylated Anthocyanins from Purple Sweet Potato (Ipomoea batatas L.) Alleviate Hyperuricemia and Kidney Inflammation in Hyperuricemic Mice: Possible Attenuation Effects on Allopurinol

Journal of Agricultural and Food Chemistry, 2019
Jiu-Liang Zhang, Qing Zhou
exaly